×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
SESSION 2: EPIDEMIOLOGY, DEFINITIONS AND CLASSIFICATION OF DILI
Session Chair(s)
Gaby L. Danan, MD, PhD
Pharmacovigilance Expert
GLD, France
- Current biomarkers of DILI: Description and limitations
- DILI risk factors
- Case studies
Speaker(s)
EPIDEMIOLOGY, DEFINITIONS AND CLASSIFICATION OF DILI
Gaby L. Danan, MD, PhD
GLD, France
Pharmacovigilance Expert
Have an account?